FindTrial
Sign In

Clinical study on the prevention and treatment of malignant ascites in patients with high risk of gastric cancer by hyperthermic intraperitoneal chemotherapy through navel

Clinical study on the prevention and treatment of malignant ascites in patients with high risk of gastric cancer by hyperthermic intraperitoneal chemotherapy through navel

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009875
Enrollment
Unknown
Registered
2016-11-15
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high risk of gastric cancer

Interventions

A:Intravenous chemotherapy
B: Hyperthermic intraperitoneal chemotherapy through navel

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Gastric cancer patients with high risk factors of recurrence after radical operation of gastric cancer

Exclusion criteria

Exclusion criteria: 1. patients with hypertension and antihypertensive drug treatment can not be reduced to the normal range; with more than grade II coronary heart disease, arrhythmia and heart failure; 2. patients with the risk of gastrointestinal bleeding; 3. patients with the risk of abnormal coagulation function with bleeding tendency; 4. patients with symptoms of central nervous system metastasis; 5. pregnant or lactating women; 6. other physicians considered unsuitable for patients.

Design outcomes

Primary

MeasureTime frame
Characters of ascites;—

Countries

China

Contacts

Public ContactHu Fei

Department of Medical Oncology, Shanghai Tenth People's Hospital

isabel062@126.com+86 021-66302521

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026